In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

The association of reduced cardiac systolic function with morphological vascular abnormality rather than functional vascular abnormality in coronary artery disease

Session Poster Session 4

Speaker Hirofumi Tomiyama

Congress : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure: Peripheral Circulation, Metabolism, Skeletal Muscle
  • Session type : Poster Session
  • FP Number : P2075

Authors : HT Tomiyama (Tokyo,JP), TC Chikamori (Tokyo,JP), AY Yamashina (Tokyo,JP)

Authors:
HT Tomiyama1 , TC Chikamori1 , AY Yamashina1 , 1Tokyo Medical University - Tokyo - Japan ,

On behalf: FMDJ study

Citation:

Aims: FMD-J study is a multicenter prospective observational study to examine the usefulness of vascular function (endothelial function and arterial stiffness) in clinical management in patients with coronary artery disease (CAD). The present cross-sectional study, as a sub-analysis of FMD-J study, was conducted to examine whether reduced cardiac systolic function is differently associated with the vascular functional or morphological abnormalities in patients with CAD.

Methods: Brachial-ankle pulse wave velocity (baPWV), a marker of arterial stiffness, and flow-mediated vasodilatation in brachial artery (FMD), a marker of endothelial function, were obtained in 674 patients with CAD at the baseline of FMD-J study.

Results: Among these patients, left ventricular ejection fraction (LVEF) <50% was observed in 83 patients. While FMD (4.3±2.6 % vs. 4.7±2..8 %, p=0.19) was similar, baPWV (15.5±2.4 m/s vs. 16.4±2.9 m/s, p<0.05) was lower, and diameter of brachial artery was larger (4.5±0.7 mm vs. 4.3±0.6 mm, p<0.05) in patients with LVEF <50% (n=83) than in those with LVEF >50% (n=591). Multivariate analysis, adjusted with age, smoking status, blood pressure, and medication for hypertension, demonstrated that LVEF was a significant determinant for brachial-arterial diameter but not baPWV.

Conclusion: In patients with CAD, reduced cardiac systolic function may be associated with vascular morphological abnormality rather than functional abnormalities.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are